Aoxing Pharmaceutical Company, Inc.
AOXG · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2 | $3 | $4 | $3 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $2 | $3 | $4 | $3 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 0% | – | – | – |
| EBITDA | -$0 | -$0 | -$0 | $0 |
| % Margin | -117.3% | – | – | – |
| Net Income | -$0 | -$0 | -$0 | $0 |
| % Margin | -117.2% | – | – | – |
| EPS Diluted | 0 | 0 | 0 | 0 |
| % Growth | – | – | -100% | – |
| Operating Cash Flow | – | – | – | – |
| Capital Expenditures | – | – | – | – |
| Free Cash Flow | – | – | – | – |